Skip to main content

Table 6 Scales, risk factors and efficiencies, overall and by diabetes duration group

From: Quality of life in chronic conditions using patient-reported measures and biomarkers: a DEA analysis in type 1 diabetes

 

All

 

0–12 years

13–23 years

24–36 years

37–75 years

 

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

 

Scales

 GenW

61

23

60

23

62

23

61

24

60

22

 

 MoE

66

22

64

23

65

22

66

22

68

22

 

 FreW

56

21

53

22

56

21

57

21

60

21

 

 ManD

65

19

63

18

64

20

64

19

68

17

 

 DiEx

57

23

57

24

56

24

57

24

60

22

 

 NLD

77

22

77

21

77

22

78

22

77

22

 

 NLBS

71

27

72

27

69

28

70

26

71

26

 

 SuDC

81

19

81

19

81

19

81

18

79

19

 

 AcDC

70

20

69

21

70

19

70

20

69

20

 

 CoDC

80

23

79

24

78

23

82

23

79

23

 

 MDMT

78

20

76

21

77

21

79

19

79

19

 

Risk factors

 HbA1c

60.9

11.9

58.9

13.0

62.0

12.4

61.7

11.0

61.0

10.7

¤

 SBP

127.4

14.3

124.0

12.6

124.9

14.3

128.1

13.9

132.3

14.6

¤

 LDL

2.44

0.76

2.56

0.79

2.46

0.69

2.42

0.74

2.34

0.81

¤

Efficiency

 Intermediate

0.68

0.17

0.67

0.18

0.67

0.18

0.68

0.17

0.71

0.16

 

 Capability

0.92

0.06

0.92

0.06

0.92

0.06

0.92

0.06

0.91

0.06

 

 GenW share (%)

10.7

10.7

10.3

10.5

11.6

12.6

10.9

10.7

9.8

9.0

 

 MoE share (%)

15.9

23.2

13.9

22.0

15.7

23.3

16.3

23.5

17.8

23.9

 

 HbA1c’ share

26.9

22.5

30.6

23.9

24.3

20.9

25.1

21.9

27.2

22.7

 

 SBP’ share

20.7

18.4

23.9

18.5

23.8

18.7

19.7

18.5

15.6

16.4

¤

 LDL’ share

25.8

22.4

21.2

20.4

24.5

22.1

28.0

23.3

29.6

22.8

¤

n

1456

 

353

 

365

 

352

 

376

  
  1. * = differences between genders (p < 0.001). ¤ = difference between duration groups (p < 0.001). SD Standard deviation